Tenax Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TENX) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M Cash from investing activities 00000 0 Cash from financing activities 92.01 M67 K23.56 M278 K3.06 M 26.97 M Free cash flow -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M

Notícias

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

Estudo de fase 3 LEVEL da Tenax Therapeutics confirma meta de recrutamento

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

Preço-alvo das ações da Tenax Therapeutics elevado para US$ 25 por Guggenheim

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

Diretor da Tenax Therapeutics, Rich Stuart, compra US$ 50.792 em ações

Tenax Therapeutics director Rich Stuart buys $50,792 in stock

Giordano buys Tenax Therapeutics (TENX) shares worth $19,999

Diretor financeiro interino da Tenax Therapeutics compra ações no valor de US$ 58.164